Aibotics, Inc.

AIBT Biotech & pharma

Develops psychedelic treatments for mental health issues.

Jun 2026Revenue $0.00/yrExpenses $1.73M/yr
No trend
Figures by year

When will Aibotics be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $0.00 and expenses $1.73M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$2.18K$1.85M−$1.84M
Dec 2024$0.00$1.63M−$1.63M
Dec 2019$0.00$252K−$252K
Dec 2018$0.00$186K−$186K